PTOtherJournal of physical therapy science2016

Automated stride assistance device improved the gait parameters and energy cost during walking of healthy middle-aged females but not those of young controls.

Risa Otsuki, Hiromi Matsumoto, Masaru Ueki and 4 others

PMID 28174452

WHAT IT FOUND

Healthy middle-aged women took longer steps and had a lower heart-rate cost during a 3-minute indoor walk when a hip-assist device was on.

Young women showed no benefit.

Key findings

01With the device on, middle-aged females' step length increased from 0.62 m to 0.67 m and walk ratio from 505 to 579; young females did not show significant changes.

02Middle-aged females' heart-rate-based energy cost was 0.33 beats per metre at 2 minutes and 0.32 at 3 minutes with assistance, compared with 0.36 without assistance.

03Young females showed no significant difference in heart-rate-based energy cost between the device-on and device-off conditions.

STILL TO COME

How it was doneWhat they foundWhat it means for PTs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

Only ten middle-aged and ten young women were studied, so the result is preliminary. The middle-aged women were healthy and had similar leg strength and standing balance to the young women, so they may not represent typical middle-aged adults. The test was a single 3-minute indoor walk, not everyday walking or long-term use. Participants were blinded to whether the device was active, but the study did not check whether they could actually feel the assistance. No people with disability or older adults were included, despite the device being discussed for those groups.

Declared interests

The authors declare no conflicts of interest.

The easy way to misread this

Do not conclude that the device is an effective long-term treatment or that it will help people with disability. The study tested a 3-minute walk in healthy middle-aged and healthy young women only, and it did not assess long-term use or disabled patients.

Read it on PubMed →